Plugging Latin America
into the future of medicine

Conectando a América Latina com o futuro da medicina

The first Latin American Digital Therapeutics company

Axenya develops software as a medicine, digital programs that delivers clinically proven therapeutic interventions to prevent, manage, or treat medical disorders or diseases. Axenya is the first (and only) Latin American member of the Digital Therapeutics Alliance, the global organization of leading digital therapeutics.

Axenya’s digital therapeutic solutions take advantage of game-changing next generation tools and services to expand the physicians’ toolbox, enhance the efficiency of healthcare delivery, make medicine more personalized and precise, and provide a new standard of care.

Axenya leverages technology to bring a revolutionary
shift to the treatment of chronic conditions

Axenya develops software as a medicine, digital programs that delivers clinically proven therapeutic interventions to prevent, manage, or treat medical disorders or diseases. Axenya is the first (and only) Latin American member of the Digital Therapeutics Alliance, the global organization of leading digital therapeutics.

‘Sick-care’ mindset

where patients are treated when symptomatic problem triggers care.

Health care mindset

where the focus is maintaining health within carefully managed parameters.

Intermittent care

where patients are treated at intervals, when they have a doctor’s appointment.

Continuous care

aided by devices, apps, AI and 24/7 event-driven monitoring.

Sickness hub

where patients come into a central location for treatment.

Multiple points of care

virtual care, remote monitoring and tele-medicine.

Low data model

with small number of signs and symptoms.

Abundant patient-generated data

through wearables and in-home devices.

‘Simulated’ enviroment

where data is taken in a controlled enviromentof a consultation office.

In-field metrics

that can follow signs and symptoms in real-time and in real-life conditions.

The first research-based
diabetes solution in the region.

• 24/7/365 remote access to care providers that supports decision making

• Real-time, hard-data and health signals that take the guessing out clinical management programs

• Personalized digital guidance that motivates action

Patients love our solutions and trust their doctors more

Net promoter Score indicates overall satisfaction with a company’s product and customers loyalty to the brand.

Net promoter Score indicates overall satisfaction with a company’s product and customers loyalty to the brand.

Improvement in trust in doctor’s treatment since using Axenya.

As a result, patients feel better and score objectively better clinical results

Patients reach and mantain clinical targets
eA1C vs baseline – less is better (%)

Patients reach and mantain clinical targets
eA1C vs baseline – less is better (%)

Nossos pacientes sentem aumento no conforto com o gerenciamento da Diabetes